Ziopharm Oncology reported $0 in Loan Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 28458M 2671M
Arena Pharmaceuticals ARNA:US $ 38.78M 1.25M
AstraZeneca AZN:LN 24601M 6727M
Baxter International BAX:US $ 5710M 29M
Biogen BIIB:US $ 6272.3M 996.9M
Bristol Myers Squibb BMY:US $ 42503M 2002M
Corcept Therapeutics CORT:US $ 0M 0M
Curis CRIS:US $ 0M 0M
Eleven Biotherapeutics EBIO:US $ 0 0
GlaxoSmithKline GSK:LN 20442M 2605M
Immunogen IMGN:US $ 0M 0M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Karyopharm Therapeutics KPTI:US $ 301.38M 59.58M
Novartis NOVN:VX SF 26491M 908M
Ptc Therapeutics PTCT:US $ 1115.38M 3.45M
Regeneron Pharmaceuticals REGN:US $ 1979.2M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Verastem VSTM:US $ 20.33M 0.65M
YTE INCY:US $ 31.84M 0.32M
Ziopharm Oncology ZIOP:US $ 0M 0M